Please Wait
Applying Filters...
Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2024/09/15/2946281/0/en/MacroGenics-Announces-Updated-Efficacy-Safety-Data-from-TAMARACK-Phase-2-Study-of-Vobra-Duo-in-mCRPC-Patients-at-ESMO-Congress-2024.html

GLOBENEWSWIRE
15 Sep 2024

https://www.globenewswire.com/news-release/2024/09/08/2942475/0/en/MacroGenics-Announces-TAMARACK-Phase-2-Data-Presentation-at-ESMO-Congress-2024.html

GLOBENEWSWIRE
08 Sep 2024

https://www.globenewswire.com/news-release/2024/07/30/2921390/0/en/MacroGenics-Provides-Vobramitamab-Duocarmazine-Update.html

GLOBENEWSWIRE
30 Jul 2024
MacroGenics' stock crashes after 5 deaths in ADC trial
MacroGenics' stock crashes after 5 deaths in ADC trial

11 May 2024

// Nick Paul Taylor FIERCE PHARMA

https://www.fiercebiotech.com/biotech/macrogenics-stock-crashes-after-5-deaths-seen-adc-trial

Nick Paul Taylor FIERCE PHARMA
11 May 2024

https://www.prnewswire.com/news-releases/byondis-esmo-late-breaking-presentation-confirms-adc-vic--trastuzumab-duocarmazine-syd985-superior-to-physicians-choice-in-pre-treated-locally-advanced-or-metastatic-her2-positive-breast-cancer-301379760.html

PRNEWSWIRE
19 Sep 2021